Soffinova Partners Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
n/a
$1.5M
($100K - $5.0M)
Investors in United Kingdom, Investors in London
n/a
$1.5M
($100K - $5.0M)
Investors in Europe, Investors in Paris (France)
Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in United Kingdom, Investors in London
n/a
$25.0M
($10.0M - $50.0M)
Investors in Europe, Investors in Canada, Investors in Montreal, Investors in Paris (France)
Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in Food and Beverage (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Food and Beverage (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Food and Beverage (Seed), Investors in Chemicals (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Food and Beverage (Series A), Investors in Chemicals (Series A), Investors in Canada (Other Lists), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed)
+21
n/a
$1.5M
($100K - $5.0M)
Investors in United Kingdom, Investors in London
+21
n/a
$1.5M
($100K - $5.0M)
Investors in Milan (Italy)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in France
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+8
n/a
$1.5M
($100K - $5.0M)
Investors in Europe, Investors in Paris (France)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in Zurich (Switzerland)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
+2
Photo of Cécile Dupont, Senior Associate at Soffinova Partners
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
Investors in BioTech (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France), Investors in Milan (Italy)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in Europe, Investors in Munich (Germany), Investors in Paris (France)
Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Gérard Hascoët, Venture Partner at Soffinova Partners
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
n/a
$1.5M
($100K - $5.0M)
Investors in New York (NY), Investors in Paris (France)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
+5
n/a
$1.5M
($100K - $5.0M)
Investors in United Kingdom, Investors in London
n/a
$1.5M
($100K - $5.0M)
Investors in Europe, Investors in Paris (France)
Investors in Material Science (Seed), Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in Food and Beverage (Seed), Investors in Food and Beverage (Series A), Investors in Chemicals (Series A), Investors in Material Science (Series A), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A)
+6
n/a
$1.5M
($100K - $5.0M)
Investors in Europe, Investors in Paris (France)
n/a
$1.5M
($100K - $5.0M)
Investors in Europe, Investors in Paris (France)
Investors in BioTech (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
Investors in BioTech (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in Milan (Italy)
Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Henrijette Richter, Managing Partner at Soffinova Partners
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
n/a
$1.5M
($100K - $5.0M)
Investors in Milan (Italy)
Photo of Martin Rothman, Venture Partner at Soffinova Partners
n/a
$1.5M
($100K - $5.0M)
Investors in California
Photo of Monique Saulnier, Managing Partner at Soffinova Partners
n/a
$1.5M
($100K - $5.0M)
Investors in Paris (France)
Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Graziano Seghezzi, Managing Partner at Soffinova Partners
n/a
$1.5M
($100K - $5.0M)
Investors in Europe, Investors in Paris (France)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Silvano Spinelli, Venture Partner at Soffinova Partners
n/a
$1.5M
($100K - $5.0M)
Investors in Italy
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
n/a
$1.5M
($100K - $5.0M)
Investors in Milan (Italy), Investors in Paris (France)
n/a
$1.5M
($100K - $5.0M)
Investors in Europe, Investors in Paris (France)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)